|
Boster Bio
nrf2 ![]() Nrf2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/nrf2/product/Boster Bio Average 93 stars, based on 1 article reviews
nrf2 - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
|
Merck & Co
rabbit monoclonal antibody anti-nrf2 ![]() Rabbit Monoclonal Antibody Anti Nrf2, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rabbit monoclonal antibody anti-nrf2/product/Merck & Co Average 90 stars, based on 1 article reviews
rabbit monoclonal antibody anti-nrf2 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Boster Bio
anti-phospho-nrf2 (s40) nfe2l2 rabbit monoclonal antibody ![]() Anti Phospho Nrf2 (S40) Nfe2l2 Rabbit Monoclonal Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti-phospho-nrf2 (s40) nfe2l2 rabbit monoclonal antibody/product/Boster Bio Average 93 stars, based on 1 article reviews
anti-phospho-nrf2 (s40) nfe2l2 rabbit monoclonal antibody - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: PLOS ONE
Article Title: Chronic intermittent hypoxia aggravated diabetic cardiomyopathy through LKB1/AMPK/Nrf2 signaling pathway
doi: 10.1371/journal.pone.0296792
Figure Lengend Snippet: (A-E) Representative blot images and quantitative analysis of LKB1, AMPK, Nrf2, HO-1. (F-G) Representative blot images and quantitative analysis of Nuclear-Nrf2. (H-I) Representative images of Nuclear-Nrf2 and the quantitative analysis for Nuclear-Nrf2 (scale bar, 100 μm). n = 3. Data are presented as means ± S.E.M. * p < 0.05 and ** p < 0.01 vs. db/m group; Φ p < 0.05 and ΦΦ p < 0.01 vs. db/db group.
Article Snippet: Seal with 5% skim milk powder sealing solution for 2 h, adding primary antibody and incubating overnight at 4°C: Tubulin (1:10000, GTX628802) and Caspase-3(1:1000, #14220) from CST; p-AMPK (1:2000, AP0116) and HO-1(1:1000, A1346) from ABclonal; PI3K (1:1000, AF6241) from Affinity; LKB1 (1:1000, 10746-1-AP), p-LKB1 (1:5000, 80127-1-RR), AMPK (1:500, 10929-2-AP), p-AKT (1:5000, 66444-1-Ig), AKT (1:5000, 60203-2-Ig), GLUT4 (1:3000, 66846-1-Ig) from Proteintech; Bax (1:1000, GB12690) from Seville; Bcl-2 (1:1000, BA0412) and
Techniques:
Journal: PLOS ONE
Article Title: Chronic intermittent hypoxia aggravated diabetic cardiomyopathy through LKB1/AMPK/Nrf2 signaling pathway
doi: 10.1371/journal.pone.0296792
Figure Lengend Snippet: (A) The cell viability of H9C2 cells was treated with HG with 0, 10, 30, and 50mM for 24 and 48 h. (B) The H9C2 cells were treated with IH and HG for 24 and 48 h, and cell viability of H9C2 cells was measured. (C) The cell viability of H9C2 cells treated with IH and HG. n = 6. (D-E) Representative images of mitochondrial membrane potential and quantitative analysis of the JC-1 ratio. n = 4. (F-G) Representative images of ROS and quantitative analysis of ROS. (H-K) Representative blot images and quantitative analysis of LKB1, AMPK, and Nrf2. n = 3. Data are presented as means ± S.E.M. * p < 0.05 and ** p < 0.01 vs. CON group; Φ p < 0.05 and ΦΦ p < 0.01 vs. HG group.
Article Snippet: Seal with 5% skim milk powder sealing solution for 2 h, adding primary antibody and incubating overnight at 4°C: Tubulin (1:10000, GTX628802) and Caspase-3(1:1000, #14220) from CST; p-AMPK (1:2000, AP0116) and HO-1(1:1000, A1346) from ABclonal; PI3K (1:1000, AF6241) from Affinity; LKB1 (1:1000, 10746-1-AP), p-LKB1 (1:5000, 80127-1-RR), AMPK (1:500, 10929-2-AP), p-AKT (1:5000, 66444-1-Ig), AKT (1:5000, 60203-2-Ig), GLUT4 (1:3000, 66846-1-Ig) from Proteintech; Bax (1:1000, GB12690) from Seville; Bcl-2 (1:1000, BA0412) and
Techniques: Membrane
Journal: PLOS ONE
Article Title: Chronic intermittent hypoxia aggravated diabetic cardiomyopathy through LKB1/AMPK/Nrf2 signaling pathway
doi: 10.1371/journal.pone.0296792
Figure Lengend Snippet: (A-B) Representative images of mitochondrial membrane potential and quantitative analysis of the JC-1 ratio. (C-D) Representative images and quantitative analysis of ROS. (E-G) Representative blot images and quantitative analysis of AMPK and Nrf2. n = 3. Data are presented as means ± S.E.M. * p < 0.05 and ** p < 0.01 vs. CON group; Φ p < 0.05 and ΦΦ p < 0.01 vs. IH+HG group.
Article Snippet: Seal with 5% skim milk powder sealing solution for 2 h, adding primary antibody and incubating overnight at 4°C: Tubulin (1:10000, GTX628802) and Caspase-3(1:1000, #14220) from CST; p-AMPK (1:2000, AP0116) and HO-1(1:1000, A1346) from ABclonal; PI3K (1:1000, AF6241) from Affinity; LKB1 (1:1000, 10746-1-AP), p-LKB1 (1:5000, 80127-1-RR), AMPK (1:500, 10929-2-AP), p-AKT (1:5000, 66444-1-Ig), AKT (1:5000, 60203-2-Ig), GLUT4 (1:3000, 66846-1-Ig) from Proteintech; Bax (1:1000, GB12690) from Seville; Bcl-2 (1:1000, BA0412) and
Techniques: Membrane
Journal: International Journal of Molecular Sciences
Article Title: Impact of Extremely Low-Frequency Electromagnetic Fields on Skeletal Muscle of Sedentary Adult Mice: A Pilot Study
doi: 10.3390/ijms25189857
Figure Lengend Snippet: Anti-oxidative enzyme expression levels and activity. ( A ) Representative immunoblots of pNRF2, SOD1, SOD2, and catalase ( Left panels ) and the corresponding densitometric analyses ( Right panels ) in skeletal muscles from mice groups after 1-week exposure (0.0, 0.1, or 1.0 mT ELF-EMFs) during which they were fed a diet without or with (+NAC) NAC supplementation. ( B ) Total antioxidant status (expressed as nM Trolox equivalent/μg protein) measured by TEAC assay (see ) in the same skeletal muscle samples tested in ( A ). ( C ) Catalase enzymatic activity (expressed as µmoles H 2 O 2 /min/mL) in the same skeletal muscle samples tested in ( A ). ( D ) Representative immunoblots of pNRF2, SOD1, SOD2, and catalase ( Left panels ) and the corresponding densitometric analyses ( Right panels ) in skeletal muscle from mice groups after 5 weeks of exposure (0.0, 0.1, or 1.0 mT ELF-EMFs), during which they were fed a diet without or with (+NAC) NAC supplementation. ( E ) Total antioxidant status (expressed as nM Trolox equivalent/μg protein) measured by TEAC assay (see ) in the same skeletal muscle samples tested in ( D ). ( F ) Catalase enzymatic activity (expressed as µmoles H 2 O 2 /min/mL) in the same skeletal muscle samples tested in ( D ). All densitometric analyses were calculated as the ratio between OD × mm 2 of each band and OD × mm 2 of the corresponding loading control band (NRF2 for pNRF2, or GAPDH for SOD1, SOD2, and catalase). All data are expressed as means ± S.E.M. from six independent experiments. * p < 0.05 and ** p < 0.01 versus 0.0 mT without NAC supplementation; # p < 0.05 versus 0.0 mT with NAC supplementation.
Article Snippet:
Techniques: Expressing, Activity Assay, Western Blot, Muscles, Control
Journal: International Journal of Molecular Sciences
Article Title: Impact of Extremely Low-Frequency Electromagnetic Fields on Skeletal Muscle of Sedentary Adult Mice: A Pilot Study
doi: 10.3390/ijms25189857
Figure Lengend Snippet: Primary antibodies used for Western blot analyses.
Article Snippet:
Techniques: Western Blot, Control